Which has the lower trailing P/E, EXEL or TECH?

EXEL has the lower trailing P/E: EXEL trades at 16.95 and TECH at 62.34. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, EXEL or TECH?

Over the past five years, EXEL grew revenue faster — EXEL at a 16.06% CAGR versus TECH at 5.47%.

Does EXEL or TECH pay a bigger dividend?

TECH pays a dividend (0.44% yield), while EXEL has no payments in the available dividend history.

Is EXEL or TECH more profitable?

EXEL runs the higher net margin — EXEL at 35.33% versus TECH at 14.97%.

How have EXEL and TECH total returns compared?

Over the past 10 years, EXEL delivered 17.26% and TECH delivered 11.11% annualized total return. Past performance doesn't predict future results.

Exelixis, Inc. (EXEL) vs Bio-Techne Corporation (TECH)

A side-by-side comparison of Exelixis, Inc. and Bio-Techne Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 21, 2026. Differences are shown without an overall score or investment verdict.

EXEL

Exelixis, Inc.

$13.59B

$54.08HealthcareDelayed quote: Aug 21, 2026, 4:00 PM EDT

TECH

Bio-Techne Corporation

$11.32B

$72.32HealthcareDelayed quote: Aug 21, 2026, 4:00 PM EDT

Total return — EXEL vs TECH

growth of $100 · dividends reinvested · last 10y

EXEL +393.4% (+17.3%/yr)TECH +190.0% (+11.2%/yr)EXEL compounded faster over this window

EXEL TECH

EXEL vs TECH: by the numbers

•EXEL is the larger company ($13.59B vs $11.32B market cap).
•EXEL trades at the lower trailing earnings multiple (16.95 vs 62.34 P/E), one valuation lens rather than an overall verdict.
•EXEL converts more revenue to profit (35.33% vs 14.97% net margin).
•EXEL grew revenue faster over the past five years (16.06% vs 5.47% CAGR).
•TECH pays a dividend (0.44% yield), while EXEL has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	EXEL	TECH
P/E ratio	16.95	62.34
Forward P/E	18.14	37.61
P/S ratio	5.77	9.35
P/B ratio	7.62	5.39
EV / EBITDA	13.93	32.54
FCF yield	8.41%	2.32%

Profitability

Metric	EXEL	TECH
Gross margin	96.48%	65.77%
Operating margin	39.88%	20.73%
Net margin	35.33%	14.97%
ROE	46.68%	8.63%
ROIC	37.87%	7.86%

Dividends

Metric	EXEL	TECH
Dividend yield	N/A	0.44%
Payout ratio	N/A	27.35%

Growth (annualized)

Metric	EXEL	TECH
Revenue CAGR (5Y)	16.06%	5.47%
EPS CAGR (5Y)	51.51%	5.16%
FCF CAGR (5Y)	40.17%	-3.08%
Total return CAGR (5Y)	24.00%	-9.22%

Frequently asked

Which has the lower trailing P/E, EXEL or TECH?: EXEL has the lower trailing P/E: EXEL trades at 16.95 and TECH at 62.34. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, EXEL or TECH?: Over the past five years, EXEL grew revenue faster — EXEL at a 16.06% CAGR versus TECH at 5.47%.
Does EXEL or TECH pay a bigger dividend?: TECH pays a dividend (0.44% yield), while EXEL has no payments in the available dividend history.
Is EXEL or TECH more profitable?: EXEL runs the higher net margin — EXEL at 35.33% versus TECH at 14.97%.
How have EXEL and TECH total returns compared?: Over the past 10 years, EXEL delivered 17.26% and TECH delivered 11.11% annualized total return. Past performance doesn't predict future results.

Go deeper

Full EXEL analysis Full TECH analysis Interactive comparison tool

Dig into the metrics

Exelixis P/E ratio Bio-Techne P/E ratio Bio-Techne dividend yield Exelixis ROE Bio-Techne ROE Exelixis operating margin Bio-Techne operating margin Exelixis revenue growth Bio-Techne revenue growth Exelixis free cash flow Bio-Techne free cash flow

Exelixis & Bio-Techne appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 21, 2026.